Filing Details
- Accession Number:
- 0001179110-12-017781
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-17 17:10:30
- Reporting Period:
- 2012-12-13
- Filing Date:
- 2012-12-17
- Accepted Time:
- 2012-12-17 17:10:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274792 | Merrimack Pharmaceuticals Inc | MACK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1531959 | R. Fazal Khan | C/O Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 | Svp Of Manufacturing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-12-13 | 25,000 | $1.71 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-12-13 | 25,000 | $6.73 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-12-17 | 25,000 | $1.71 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-12-17 | 25,000 | $6.41 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2012-12-13 | 25,000 | $0.00 | 25,000 | $1.71 |
Common Stock | Stock Option (right to buy) | Disposition | 2012-12-17 | 25,000 | $0.00 | 25,000 | $1.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
125,000 | 2016-02-24 | No | 4 | M | Direct | |
100,000 | 2016-02-24 | No | 4 | M | Direct |
Footnotes
- This option is fully vested.